A key role for an impaired detoxification mechanism in the etiology and severity of autism spectrum disorders by unknown
Alabdali et al. Behavioral and Brain Functions 2014, 10:14
http://www.behavioralandbrainfunctions.com/content/10/1/14RESEARCH Open AccessA key role for an impaired detoxification
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Background: Autism Spectrum Disorders (ASD) is a syndrome with a number of etiologies and different
mechanisms that lead to abnormal development. The identification of autism biomarkers in patients with different
degrees of clinical presentation (i.e., mild, moderate and severe) will give greater insight into the pathogenesis of
this disease and will enable effective early diagnostic strategies and treatments for this disorder.
Methods: In this study, the concentration of two toxic heavy metals, lead (Pb) and mercury (Hg), were measured in
red blood cells, while glutathione-s-transferase (GST) and vitamin E, as enzymatic and non-enzymatic antioxidants,
respectively, were measured in the plasma of subgroups of autistic patients with different Social Responsiveness Scale
(SRS) and Childhood Autism Rating Scale (CARS) scores. The results were compared to age- and gender-matched
healthy controls.
Results: The obtained data showed that the patients with autism spectrum disorder had significantly higher Pb and
Hg levels and lower GST activity and vitamin E concentrations compared with the controls. The levels of heavy metals
(Hg and Pb), GST and vitamin E were correlated with the severity of the social and cognitive impairment measures
(SRS and CARS). Receiver Operating Characteristics (ROC) analysis and predictiveness curves indicated that the four
parameters show satisfactory sensitivity, very high specificity and excellent predictiveness. Multiple regression analyses
confirmed that higher levels of Hg and Pb, together with lower levels of GST and vitamin E, can be used to predict
social and cognitive impairment in patients with autism spectrum disorders.
Conclusion: This study confirms earlier studies that implicate toxic metal accumulation as a consequence of impaired
detoxification in autism and provides insight into the etiological mechanism of autism.
Keywords: Autism Spectrum Disorder, Social Responsiveness Scale (SRS), Childhood Autism Rating Scale (CARS), Lead,
Mercury, Glutathione-s-transferase, Vitamin EIntroduction
Autism is characterized by a set of repetitious behavior
in combination with social, cognitive and communica-
tion deficits [1]. An emerging hypothesis states that
autism may result from a combination of genetic suscep-
tibility and exposure to environmental toxins at critical
periods during brain development [2]. Neurotoxins and
associated inflammation of the brain tissue are often the
focus of therapies for patients with autism. However, if* Correspondence: elansary@ksu.edu.sa
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unless otherwise stated.body detoxification is impaired, neuroinflammation will
not efficiently improve unless the overall body issues are
addressed. Xenobiotics are neurotoxins of external ori-
gin, such as chemicals and pollutants in the air, water,
food additives and drugs, that can dramatically alter the
health of the child. An efficient three-phase mechanism
is involved in detoxifying these toxins [3]; however,
several factors play a role in modulating this mechanism.
For example, age, gender and diet are among the various
biological and non-biological factors that modulate in-
dividual susceptibility. Additionally, genetic variability
plays a critical role in individual susceptibility because
variable detoxifier phenotypes result from mutations inl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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lar enzyme and detoxification functions to poor metabo-
lizers with low or no enzyme activity [4,5].
Glutathione-S-transferase (GST) functions in the de-
toxification of xenobiotics, drugs, toxins, and metabolites
and is also involved in the regulation of mitogen-activated
protein kinases, which are important during differen-
tiation and development. Hg and Pb, however, are two
well-known toxicants that have toxic effects on the body,
with the brain being the most susceptible target organ.
Exposure to Hg and Pb during pregnancy and early child-
hood can cause neurodevelopmental impairment and sub-
clinical brain dysfunction because both heavy metals can
cross the placenta and the blood–brain-barrier [6]. In the
brain, these metals can affect critical developmental pro-
cesses, including cell proliferation, migration, differen-
tiation, synaptogenesis, myelination, and apoptosis [6].
It is well documented that patients with ASD have many
statistically significant differences in their nutritional and
metabolic status compared with those who do not have
ASD. Some of these biomarkers are indicative of vitamin
E insufficiency, increased oxidative stress, and poor de-
toxification and are associated with the severity of the
disorder [7-10]. A recent study found that impaired
xenobiotic detoxification is correlated with increased gut
permeability (leaky gut) and neuroinflammation, two ac-
cepted pathological phenomena in ASD [3].
These findings prompted us to search for biochemical
correlations related to the detoxification mechanism and
neurobiological processes and the severity and social
functioning of patients with ASD measured by the CARS
and SRS. We selected Hg and Pb as two environmental
toxicants involved in the etiology of ASD, together with
GST and vitamin E as enzymatic and non-enzymatic an-
tioxidants with high activity in terminating lipid peroxi-
dation and environmental toxicity. We hypothesized that
confirming the relationship between impaired detoxifica-
tion mechanism and severity of ASD could enhance ef-
forts at early prevention, diagnosis, and intervention
and, thus, may play a role in decreasing the prevalence
of autism.
Material and methods
Subjects
This cross-sectional study was conducted on 52 autistic
male children who were recruited from the Autism
Research and Treatment Center, Faculty of Medicine, King
Saud University, Riyadh, Saudi Arabia. Of these children,
40 were nonverbal, and 12 were verbal. Their ages ranged
between 3 and 12 years (mean SD= 7.0 ± 2.34 years). The
control group was comprised of 30 age- and sex-matched
apparently healthy children with a mean age of 7.2 ±
2.14 years. The patients fulfilled the diagnostic criteria of
autism described in the 4th edition of the Diagnostic andStatistical Manual of Mental Disorders. The controls were
normally developing, healthy children who were unrelated
to the autistic subjects and did not have any of the exclu-
sion criteria. The control children were the healthy older
siblings of healthy infants who were attending the Well
Baby Clinic at King Khalid University Hospital for routine
check-ups of their growth parameters. They had no clinical
indications of infectious diseases or neuropsychiatric disor-
ders. All participants had normal results for urine analysis
and sedimentation rate. The local Ethical Committee of
the Faculty of Medicine, King Saud University, Riyadh,
Saudi Arabia, approved this study. In addition, an in-
formed written consent of participation for this study
was signed by the parents or the legal guardians of
the investigated subjects, according to the Helsinki
principles. The selected sample of participants was
based on how convenient and readily available the
group of participants was (i.e., convenience sampling).
Participants were excluded from the study if they had
a diagnosis of fragile X syndrome, epileptic seizures,
obsessive–compulsive disorder, affective disorders, or
any additional psychiatric or neurological diagnoses.
Measurement of Autism severity scales (CARS and SRS)
The Childhood Autism Rating Scale (CARS) score, which
is a measurement of the severity of the disease, rates the
child on a scale from one to four in each of fifteen areas
(relating to people’s emotional response; imitation; body
use; object use; listening response; fear or nervousness;
verbal communication; non-verbal communication; acti-
vity level; level and reliability of intellectual response;
adaptation to change; visual response; taste, smell and
touch response and general impressions). According to
the scale, children who scored 30–36 had mild to mode-
rate autism (n = 23), while those with scores ranging bet-
ween 37 and 60 points had severe autism (n = 27) [11,12].
To calculate a score for the Social Responsiveness Scale,
a questionnaire was completed in 15 to 20 minutes. A
total score of 76 or higher was considered severe and
strongly associated with a clinical diagnosis of autistic dis-
order. A score of 60–75 was interpreted as falling in the
mild to moderate range of social impairment [13].
Sample collection
After an overnight fast, 10-ml blood samples, from both
groups of children, were collected in test tubes containing
sodium heparin as an anticoagulant. The tubes were cen-
trifuged at 3500 rpm for 15 minutes at room temperature.
Plasma and red blood cells were separated and stored at −
80°C until required for analysis.
Biochemical analysis
Plasma is a complex bodily fluid containing proteins, pep-
tides, lipids and metabolites and can reflect physiological
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the CNS. In humans, approximately 500 ml of CSF is
absorbed into the blood daily, making blood a suitable
source of biomarkers of neurodegenerative or neurodeve-
lopmental diseases [14]. All biochemical assays were per-
formed in duplicate and blinded to the clinical status of
the participants.
1- Measurement of mercury
The concentration of inorganic mercury (Hg) in red blood
cells was determined by the method described by Magos
[15] using a flameless atomic-absorption method. The red
blood cells were diluted with saline to 20 ml, followed by
the addition of 1 ml of a 1% cysteine solution, 10 ml of
8 M H2SO4 and 1 ml of SnCl2 (100 mg/ml). The sample
was subjected to immediate aeration at a constant rate of
2.5 l/min through the reaction vessel, and 20 ml of a 45%
NaOH was added. The SnCl2 reagent was used to release
all of the inorganic mercury from the samples. Aeration
was discontinued after the recorder pen had settled back
to within a few chart divisions (2 or 3) of its originalTable 1 Mercury (μg/L), lead (μg/dl), GST (μmol/l) and vitamin
Parameters Group
Mercury (μg/L) Control
Patients with autism
Autism (mild to moderate in CARS)
Autism (severe in CARS)
Autism (mild to moderate in SRS)
Autism (severe in SRS)
Lead (μg/dl) Control
Patients with autism
Autism (mild to moderate in CARS)
Autism (severe in CARS)
Autism (mild to moderate in SRS)
Autism (severe in SRS)
GST (μmol/min/ml) Control
Patients with autism
Autism (mild to moderate in CARS)
Autism (severe in CARS)
Autism (mild to moderate in SRS)
Autism (severe in SRS)
Vitamin E (nmol/L) Control
Patients with autism
Autism (mild to moderate in CARS)
Autism (severe in CARS)
Autism (mild to moderate in SRS)
Autism (severe in SRS)
aP value between mild to moderate and severe in CARS and SRS.
bP value between control and autistic groups.baseline, which was approximately 1 to 1.5 min, depending
on the actual aeration rate. The concentration of mercury
was measured using a flameless atomic-absorption me-
thod, and the concentration was calculated using a stan-
dard calibration curve prepared using a standard Hg
concentration.
2- Measurement of Pb
Lead levels were measured in red blood cells using adap-
tations of the methods described by Miller et al. [16]
and Parsons and Slavin [17]. Briefly, RBCs (0.1 ml) were
resuspended and digested in 3.9 ml of 0.5 N nitric acid.
Lead quantification was based on the measurement of
light absorbed at 283.3 nm by the ground-state atoms of
Pb from a hollow cathode lamp (HCl) source.
3- Determination of glutathione-S-transferase activity (GST)
GST activity was assessed in the plasma using an assay
kit (Biovision, USA). The kit is based on a GST-catalyzed
reaction between GSH and the GST substrate, CDNB
(1-chloro-2, 4-dinitrobenzene). The GST-catalyzed formationE (nmol/L) levels in the control & autistic groups
N Mean ± S.D. P valuea P valueb
32 5.12 ± 0.83
58 6.99 ± 0.94 0.001
29 6.49 ± 0.65
0.042
0.001
28 7.31 ± 0.49 0.001
22 7.02 ± 0.85
0.050
0.001
22 7.46 ± 0.59 0.001
32 4.73 ± 0.67
58 6.79 ± 0.97 0.001
29 6.34 ± 0.82 0.041 0.001
28 6.80 ± 0.83 0.001
22 6.42 ± 0.84 0.040 0.001
22 6.95 ± 0.81 0.001
30 0.61 ± 0.17
30 0.30 ± 0.08 0.001
18 0.31 ± 0.07
0.043
0.001
12 0.26 ± 0.07 0.001
8 0.32 ± 0.07
0.027
0.001
18 0.25 ± 0.06 0.001
27 25.44 ± 2.62
28 14.45 ± 2.28 0.001
11 14.56 ± 1.58
0.048
0.001
17 13.36 ± 1.47 0.001
11 14.85 ± 1.36
0.044
0.001
12 13.35 ± 1.14 0.001
Figure 1 Mean levels of A) mercury (μg/L), B) lead (μg/L),
C) GST (μmol/min/ml) and D) vitamin E (nmol/L) of the autistic
groups compared with age- and sex-matched controls. The
mean value for each group is designated by a line.
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can be detected by a spectrophotometer at 340 nm. GST
activity was expressed as μmole/min/ml plasma.
4- Vitamin E assay (α -tocopherol)
Plasma vitamin E was assessed using high pressure liquid
chromatography (HPLC) as described by Driskell et al.
[18]. The separation via HPLC follows an isocratic method
at 30°C using a “reversed phase” column; one run lasts
15 minutes. The detection was performed with a UV de-
tector at 290 nm. The quantification was performed with
the delivered standard solution; the concentration was cal-
culated via the integration of the peak areas in the internal
standard calibration mode.
Statistical analysis
The Statistical Package for the Social Sciences (SPSS)
computer program was used. The results were expressed
as the mean ± SD, and all statistical comparisons were
made by means of independent t-tests, with P ≤0.05 con-
sidered as significant. ROC analysis was performed. Areas
under the curve and cut off values were selected by the
program. The degree of specificity and sensitivity were cal-
culated. Moreover, the predictiveness diagrams of the four
measured parameters were drawn using a Biostat 16 com-
puter program in which the x axis represents percentile
rank of the biomarker, the y axis represents the probability
of identifying the disease and the horizontal line is the
prevalence of the disease. Enter and stepwise multiple re-
gression analyses were performed using CARS and SRS as
two dependent variables and Hg, Pb, GST and vitamin E
as independent variables.
Results
Table 1 and Figure 1 present the mean ± SD of Hg, Pb
and plasma GST and vitamin E levels in RBCs of the
control, severe autistic and mild-moderate autistic pa-
tients with different CARS and SRS scores. Mercury and
Pb were significantly elevated in the autistic patients
compared with the controls, with increases of 36.58%
and 43.34%, respectively. GST and vitamin E levels
decreased by 50.71% and 43.18% percent, respectively
(Figure 2).
Table 2 and Figure 3 show the ROC analysis of the
four measured parameters. The area under the curve
(AUC), specificity and sensitivity are illustrated. Figure 4
shows the predictiveness curves of the four measured
parameters exhibiting high and low risk in relation to
the prevalence of autism in Saudi Arabia.
Figure 2 Percentage change of A) mercury, B) lead, C) GST and D) vitamin E in the autistic group relative to the control group, which
is represented as 100%.
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Table 2 ROC-curve of mercury (μg/L), lead (μg/dl), GST (μmol/l) and vitamin E (nmol/L) levels in the autistic groups
Parameters
Autistic
patients
CARS SRS
Mild to moderate Severe Mild to moderate Severe
Mercury Area under the curve 0.926 0.961 1.000 0.935 0.997
Best cutoff value 6.018 6.018 6.316 6.105 6.346
Sensitivity % 84.5% 93.1% 100.0% 86.4% 95.5%
Specificity % 93.8% 93.8% 100.0% 96.9% 100.0%
Lead Area under the curve 0.953 0.917 0.980 0.923 0.980
Best cutoff value 5.586 5.590 6.132 6.132 6.321
Sensitivity % 89.7% 79.3% 89.3% 72.7% 86.4%
Specificity % 87.5% 87.5% 96.9% 96.9% 100.0%
GST Area under the curve 0.980 0.974 1.000 0.983 1.000
Best cutoff value 0.443 0.443 0.320 0.443 0.320
Sensitivity % 100.0% 100.0% 100.0% 100.0% 100.0%
Specificity % 93.3% 93.3% 100.0% 93.3% 100.0%
Vitamin E Area under the curve 0.999 1.000 1.000 1.000 1.000
Best cutoff value 19.254 18.718 18.089 18.718 17.953
Sensitivity % 96.4% 100.0% 100.0% 100.0% 100.0%
Specificity % 100.0% 100.0% 100.0% 100.0% 100.0%
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ween the four measured parameters in this study. The
results showed that while Pb and Hg were positively
correlated with each other, both metals were negatively
correlated with GST and vitamin E as enzymatic and
non-enzymatic detoxifiers.
Tables 4, 5, 6 and 7 show multiple regression analysis
results using the Enter method (Tables 4 & 6) and
Stepwise method (Tables 5 & 7) for the CARS and SRS
scores as two dependent variables, respectively. The
value of R2 shows that 0.56 or 56% of the variance of the
CARS scores and almost 40% of the variance of the SRS
scores were explained by the regression of the four mea-
sured parameters, with GST and vitamin E being more
predictive (stepwise regression as presented in Tables 5
& 7).
Discussion
Exposure to even low levels of lead (Pb) early in life has
adverse effects on a variety of cognitive and behavioral
functions and neurochemical systems, resulting in deficits
in learning, memory and attention that may persist into
adulthood [19-22]. Persistent effects of Pb exposure early
in life can produce changes that arise from physiological
re-programming [23]. In this study, there was a significant
increase in Pb levels in patients with ASD compared with
the control group, coupled with a correlation between Pb
concentration and the severity of SRS and CARS scores.
These observations support a recent study on patientswith ASD by Schneider et al. (2013) [24], who suggested
potential epigenetic effects of developmental Pb exposure
on DNA methylation. These effects were mediated at least
partially through the dysregulation of methyltransferases
as multiple forms of proteins, at least some of which are
potentially involved in cognition [25], and the resulting
abnormalities were recorded in patients with ASD [26].
The reported elevation of Hg and Pb in the RBCs of pa-
tients with ASD compared with the control subjects
(Table 1 and Figure 1A&B) can be related to and support
a previous study by Al-Yafee et al. [27] in which Saudi pa-
tients with ASD were described as poor detoxifiers with a
lower GSH/GSSG ratio and remarkably less active GST
and thioredoxin reductase as markers of the detoxification
mechanism. It is well known that GSH and GST are both
critical for the detoxification of mercury [28]. While GSH
carries Hg through biliary transport for excretion, Hg2+
rapidly oxidizes glutathione [28]. This observation is cor-
related with the previous work of Al-Gadani et al. [8] who
reported lower GSH in the plasma of Saudi patients with
ASD. Additionally, the increase of Hg and Pb recorded in
this study is consistent with previous studies. For example,
Blaurock-Busch et al. [29] found a significant increase of
both toxicants in the hair of autistic children compared
with non-autistic children. This observation may indicate
an impaired detoxification mechanism as a risk factor that
significantly contributes to the etiology of autism. The
exposure of patients with ASD in early childhood to
mercury vapor, methylmercury and ethylmercury may
Figure 3 ROC-curves for A) mercury, B) lead, C) GST and D) vitamin E in the autistic groups.
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tions [30-32].
Furthermore, in this study, remarkably higher levels of
Hg and Pb were recorded in patients with severe social
and cognition impairment (SRS & CARS) compared
with those with mild-moderate abnormalities. This ob-
servation suggests that heavy metal toxicity is closely
related to the pathophysiology of autism. This outcome
does not concur with a study by Elsheshtawy et al. in
which Hg, but not Pb, was found in the hair of autistic
patients as a biochemical correlate to disease severity
(CARS) [33]. However, our results are consistent with
the recent work of Adams et al. [34] who reported that
children with autism have higher average levels of se-
veral toxic metals, among which Hg and Pb are stronglyassociated with variations in the severity of the disorder.
However, in their study, Adams et al. found a non-
significant difference of Hg in children with autism vs.
neurotypical children. This could be attributed to diffe-
rences in geographic exposure to mercury (Saudi Arabia
vs. Arizona). Patients with autism are poor detoxifiers
(i.e., unable to detoxify mercury when it reaches a cer-
tain level) [27]. Therefore, this could indicate a higher
rate of exposure to Hg in the Saudi population com-
pared with the population in Arizona.
Face recognition is a core deficit of social impairment
in autism. A number of studies indicate that norepi-
nephrine (NE) and dopamine (DA) modulate and reduce
behavioral responses to changes in the social environ-
ment [35,36]. In addition, serotonin (5HT) transporter
Figure 4 Predictiveness curve for A) mercury, B) lead, C) GST
and D) vitamin E in the autistic patients.
Table 3 Statistically significant Pearson’s correlation
between the four measured parameters
Parameters R (Person correlation) Sig.
GST ~ Mercury −0.613 0.001** Nb
GST ~ Lead −0.588 0.001** Nb
GST ~ Vitamin E 0.696 0.001** Pa
Mercury ~ Lead 0.761 0.001** Pa
Mercury ~ Vitamin E −0.710 0.001** Nb
Lead ~ Vitamin E −0.715 0.001** Nb
aPositive correlation.
bNegative correlation.
**Correlation is significant at the 0.01 level (2-tailed).
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known to play an important role in social cognition and
behavior [37], and 5HT binding potential is negatively
correlated with social impairment. Therefore, recording
Pb as a correlate to severity of SRS and CARS scores in
the present study is consistent with the recent findings
of El-Ansary et al. [38] in which a positive association
was observed between chronic Pb toxicity and lower
levels of neurotransmitters as markers of neurologic in-
jury in autistic brains in a Saudi population. Alternately,
the biochemical correlation between Pb and the severity
of autism is in agreement with other studies. Szkup-
Jabłońska et al. [39] and Blaurock-Busch et al. [40]
reported a significant correlation between Pb and fear,
nervousness, verbal and nonverbal communication, social
activity level, and consistency of intellectual response.
Moreover, the positive correlation between elevated Pb
toxicity and both autistic scales could be supported by the
fact that Pb exposure affects multiple health outcomes
and physiological systems [41]. These include behavioral/
cognitive/IQ effects, nerve conductive effects, hearing
loss, reproduction and development effects and death
from encephalopathy. Long-term trends in population ex-
posure to Pb (indexed through use of leaded petrol and
paint) were remarkably consistent with the link between
IQ and social behavior [42].
The significant reduction in plasma GST in Saudi pa-
tients with autism compared with controls is docu-
mented in this study (Table 1 and Figure 1C&D). ThisTable 4 Multiple regression using the enter method for
CARS as a dependent variable
Model Beta P value Adjusted R2 Model
F value P value
(Constant) 3.038 0.005
0.564 25.907 0.001
Mercury (μg/L) 0.161 0.139
Lead (μg/dl) 0.004 0.971
GST (μmol/l) −1.159 0.081
Vitamin E
(nmol/L)
−0.082 0.002
Table 5 Multiple regression using the stepwise method
for CARS as a dependent variable
Model Beta P value Adjusted R2 Model
F value P value
(Constant) 4.517 0.001
0.560 49.909 0.001
Vitamin E
(nmol/L)
−0.103 0.001
GST (μmol/l) −1.383 0.035
Table 7 Multiple regression using the stepwise method
for SRS as a dependent variable
Model Beta P value Adjusted R2 Model
F value P value
(Constant) 6.298 0.001
0.384 47.167 0.001Vitamin E
(nmol/L)
−0.202 0.001
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substrate of GST in the plasma of patients with ASD
compared with control subjects [8,43,44]. The reduction
in this essential detoxifying enzyme can explain the poor
detoxification in patients with ASD, leading to the Hg
and Pb toxicity discussed above.
In our study, there was an inverse relationship between
decreased levels of plasma GST and the severity of autism,
as measured by the SRS and CARS. Severely autistic cases
had a remarkably lower GST activity compared to mild-
moderate cases of autism. These outcomes concur with
Geier et al. [45], who also found a significant inverse rela-
tionship between blood GSH levels and autism severity
measured with the CARS. Mercury aggravates impaired
glutathione synthesis by depleting glutathione in lym-
phocytes and monocytes, leading to an increased risk of
immuno and cytotoxic effects.
Although, the roles and importance of various forms
of vitamin E are still unclear [46], it has been suggested
that the most important function of α-tocopherol is as a
signaling molecule playing an important role in protec-
ting neurons from damage [47]. As an antioxidant, vita-
min E may prevent or reduce the propagation of free
radicals, which are associated with physical decline, in
the human body. This may help reduce muscle or DNA
damage and prevent the development of pathological
conditions, such as autism [48]. Table 1 and Figure 1D
demonstrate the significantly reduced levels of vitamin E
in the plasma of patients with ASD compared with the
control group. Herndon et al. [49] also found decreased
vitamin E levels in autistic patients. The brain contains
high levels of oxidizable lipids that must be protected byTable 6 Multiple regression using the enter method for
SRS as a dependent variable
Model Beta P value Adjusted R2 Model
F value P value
(Constant) 4.844 0.028
0.391 12.867 0.001
Mercury (μg/L) 0.261 0.248
Lead (μg/dl) 0.117 0.575
GST (μmol/l) −1.890 0.185
Vitamin E
(nmol/L)
−0.134 0.012antioxidants; hence, the supplementation of ASD pa-
tients with vitamin E as a major lipophilic antioxidant
could be helpful [7,50]. The highly significant correlation
between vitamin E depletion and severity of autism, as
measured by the SRS and CARS, supports its critical
role in protecting against the toxic effects of Pb and Hg.
This is consistent with a previous report by Adams et al.
[7] that showed a significant association between vitamin
E insufficiency and the severity of the Autism Scale
(SAS).
ROC analyses of Pb, Hg, GST and vitamin E are pre-
sented in Table 2 and Figure 3(A-D). All measured pa-
rameters demonstrated almost 100% sensitivity and very
high specificity, which also confirmed the hypothesis
that autistic patients are poor detoxifiers, unable to rea-
dily excrete toxic substances (e.g., Hg and Pb), and sug-
gests that reduced GST activity and depleted vitamin E
are two critical factors related to poor detoxification.
Lead, Hg, GST and vitamin E show perfect predictive-
ness curves (Figure 4A-D). Excellent predictiveness curves
for the four parameters reflect the possibility of using any
of these parameters to follow up an antioxidant-related
treatment strategy. A successful treatment could be
followed through a remarkable elevation of plasma
vitamin E, the activation of GST or both in autistic
patients. Alternately, efficacious treatment could occur
through a reduction in Pb and Hg levels. In addition,
the relationship between vitamin E deficiency and the
etiology of autism could be ascertained by the high
specificity, sensitivity and AUC, as shown with the ROC
analysis (Table 2).
The negative correlations between Hg & Pb and vitamin
E & GST (Table 3) suggest the use of vitamin E as a non-
enzymatic antioxidant in treating patients with autism.
This suggestion is supported by the multiple regression
analysis results (Tables 4, 5, 6 and 7), confirming that
higher levels of Hg and Pb, together with lower levels of
GST and vitamin E, can be used to predict cognitive and
social impairment with the regression of both antioxidant
parameters, which is more related to abnormalities of
both.
Conclusion
The high values of both sensitivity and specificity re-
corded for Pb, Hg, GST and vitamin E, together with the
Alabdali et al. Behavioral and Brain Functions 2014, 10:14 Page 10 of 11
http://www.behavioralandbrainfunctions.com/content/10/1/14good predictiveness curves; suggest that these can be
used as biomarkers for measuring the severity of SRS
and CARS scores in a Saudi population. This study
confirmed the impaired antioxidant and detoxification
mechanisms in Saudi autistic patients. Hence, early in-
tervention through the supplementation of good quality
and safe antioxidants, including vitamin E, carnosine
and selenium, can be helpful in decreasing the burden of
heavy metal toxicity. Vitamin E exists in eight different
forms: four tocopherols and four tocotrienols. The mea-
sured form of vitamin E, α –tocopherol, is one of the
forms that regulate signal transduction pathways by
mechanisms that are independent of its antioxidant
properties, and its use as a supplement can be effective
in reducing the toxicity burden in these patients. Autis-
tic children who undergo intensive intervention have
better social interaction than children who do not.
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